Stay updated on DeRIVE for Newly Diagnosed Myeloma Clinical Trial
Sign up to get notified when there's something new on the DeRIVE for Newly Diagnosed Myeloma Clinical Trial page.

Latest updates to the DeRIVE for Newly Diagnosed Myeloma Clinical Trial page
- Check4 days agoChange DetectedAdded revision: v3.4.3 and removed revision: v3.4.2.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No visible changes to the study details or user-facing content were detected.SummaryDifference0.0%

- Check40 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page shows a revision update from v3.3.3 to v3.3.4 with no visible changes to study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedLocations now lists Georgia as a study site. The page revision is updated to v3.3.3 and the Georgia Locations entry along with the HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

- Check112 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2; no changes to study content, eligibility criteria, or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to DeRIVE for Newly Diagnosed Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DeRIVE for Newly Diagnosed Myeloma Clinical Trial page.